Polyelectrolyte complex of carboxymethyl starch and chitosan as drug carrier for oral administration

被引:71
作者
Assaad, Elias [1 ,2 ]
Wang, Yu Juan [3 ]
Zhu, Xiao Xia [3 ]
Mateescu, Mircea Alexandru [1 ,2 ]
机构
[1] Univ Quebec Montreal, Dept Chem, Montreal, PQ H3C 3P8, Canada
[2] Univ Quebec Montreal, Pharmaqam Ctr, Montreal, PQ H3C 3P8, Canada
[3] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Carboxymethyl starch; Chitosan; Polyelectrolyte complex; Coexcipient; Monolithic tablet; Drug delivery; HIGH-AMYLOSE STARCH; IN-VITRO; VISCOMETRIC CONSTANTS; STRUCTURAL INSIGHTS; TABLETS; RELEASE; TEMPERATURE; FORMULATION; EXCIPIENT; DELIVERY;
D O I
10.1016/j.carbpol.2011.01.048
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A novel polyelectrolyte complex (PEC) of carboxymethyl starch (CMS) and chitosan was prepared, characterized and tested in vitro as a carrier for oral drug delivery. This PEC, containing 14% (w/w) of chitosan, showed a polymorphism with a lower order degree than those of CMS and of chitosan. Under conditions simulating the gastrointestinal transit, NMR imaging analysis showed slower fluid diffusion inside PEC monolithic tablets than inside CMS tablets. The PEC seems to be a more suitable drug carrier for colon targeting than CMS, since it can prolong acetaminophen release tine from 8 h to 11 h and aspirin release time from 13 h to 30 h. In contrast, chitosan used as a coexcipient accelerated aspirin release from matrices based on a CMS:chitosan physical mixture. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1399 / 1407
页数:9
相关论文
共 47 条
[1]  
Assaad E., 2008, T 35 ANN M EXP CRS N
[2]   The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics [J].
Assaad, Elias ;
Mateescu, Mircea Alexandru .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 394 (1-2) :75-84
[3]   NMR Imaging of high-amylose starch tablets. 1. Swelling and water uptake [J].
Baille, WE ;
Malveau, C ;
Zhu, XX ;
Marchessault, RH .
BIOMACROMOLECULES, 2002, 3 (01) :214-218
[4]   High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release:: Formulation aspects and in vitro drug-release evaluation [J].
Brouillet, F. ;
Bataille, B. ;
Cartilier, L. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 356 (1-2) :52-60
[5]  
Broussignac P., 1968, CHIM IND GEN CHIM, V99, P1241
[6]   Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations [J].
Calinescu, C ;
Mulhbacher, J ;
Nadeau, T ;
Fairbrother, JM ;
Mateescu, MA .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (01) :53-60
[7]   Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery [J].
Calinescu, Carmen ;
Mateescu, Mircea Alexandru .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) :582-589
[8]   Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation [J].
Calinescu, Carmen ;
Nadeau, Eric ;
Mulhbacher, Jerome ;
Fairbrother, John Morris ;
Mateescu, Mircea-Alexandru .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 343 (1-2) :18-25
[9]  
Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO
[10]  
2-F